- Published on
Pathology - Thalassemias
Etiology
Thalassemias are caused by the deletion of one or more of the four genes that code for the alpha globin chain of hemoglobin in the body. This condition is known as alpha-thalassemias.
ß-Thalassemias are caused by a point mutation in the B-globin gene, which leads to a decrease or complete absence of the production of the B-globin chain of hemoglobin (Hgb).
Thalassemias are more prevalent in individuals with Mediterranean heritage.
Study of the nature and causes of diseases.
Pathology
Alpha-Thalassemias: Examination of the blood sample reveals red blood cells that are abnormally small and pale, with a characteristic appearance of target cells.
B-Thalassemias: The examination of the blood sample shows red blood cells that are pale and small in size, as well as cells with a target-like appearance and irregular shape and size variation.
Symptoms and signs
alpha-Thalassemias: There are four different clinical variations. (1) The presence of 3-4 normal genes in alpha-thalassemia trait results in an asymptomatic condition. (2) The presence of two normal genes in alpha-thalassemia trait results in mild anemia with a decrease in mean corpuscular volume (MCV).
(3) Hemoglobin H illness is characterized by severe hemolytic anemia with low mean corpuscular volume (MCV) (< 70), the presence of Hgb H (aggregate of excess ß-chains), and splenomegaly. (4) Hydrops fetalis occurs in stillborn fetuses with no normal genes present.
There are two clinical forms of ß-Thalassemias. (1) B-thalassemia minor refers to the condition of having one abnormal gene for beta-thalassemia, resulting in mild anemia and a decrease in mean corpuscular volume (MCV). (2) B-thalassemia major (homozygosity) is a condition characterized by significant destruction of red blood cells, resulting in low mean corpuscular volume (MCV). It typically manifests in infancy and is associated with elevated levels of hemoglobin E, enlargement of the spleen, and abnormalities in the bones due to expansion of the bone marrow. The patient has developed hemosiderosis as a result of receiving chronic transfusions, which has subsequently led to heart failure.
Therapy
a-Thalassemias: Alpha-thalassemia trait does not require treatment, although hemoglobin H illness may require transfusions.
ß Thalassemias: ß-thalassemia minor does not require therapy, while transfusion and/or bone marrow may be necessary for other types of ß-thalassemia.
Etiology
Thalassemias are caused by the deletion of one or more of the four genes that code for the alpha globin chain of hemoglobin in the body. This condition is known as alpha-thalassemias.
ß-Thalassemias are caused by a point mutation in the B-globin gene, which leads to a decrease or complete absence of the production of the B-globin chain of hemoglobin (Hgb).
Thalassemias are more prevalent in individuals with Mediterranean heritage.
Study of the nature and causes of diseases.
Pathology
Alpha-Thalassemias: Examination of the blood sample reveals red blood cells that are abnormally small and pale, with a characteristic appearance of target cells.
B-Thalassemias: The examination of the blood sample shows red blood cells that are pale and small in size, as well as cells with a target-like appearance and irregular shape and size variation.
Symptoms and signs
alpha-Thalassemias: There are four different clinical variations. (1) The presence of 3-4 normal genes in alpha-thalassemia trait results in an asymptomatic condition. (2) The presence of two normal genes in alpha-thalassemia trait results in mild anemia with a decrease in mean corpuscular volume (MCV).
(3) Hemoglobin H illness is characterized by severe hemolytic anemia with low mean corpuscular volume (MCV) (< 70), the presence of Hgb H (aggregate of excess ß-chains), and splenomegaly. (4) Hydrops fetalis occurs in stillborn fetuses with no normal genes present.
There are two clinical forms of ß-Thalassemias. (1) B-thalassemia minor refers to the condition of having one abnormal gene for beta-thalassemia, resulting in mild anemia and a decrease in mean corpuscular volume (MCV). (2) B-thalassemia major (homozygosity) is a condition characterized by significant destruction of red blood cells, resulting in low mean corpuscular volume (MCV). It typically manifests in infancy and is associated with elevated levels of hemoglobin E, enlargement of the spleen, and abnormalities in the bones due to expansion of the bone marrow. The patient has developed hemosiderosis as a result of receiving chronic transfusions, which has subsequently led to heart failure.
Therapy
a-Thalassemias: Alpha-thalassemia trait does not require treatment, although hemoglobin H illness may require transfusions.
ß Thalassemias: ß-thalassemia minor does not require therapy, while transfusion and/or bone marrow may be necessary for other types of ß-thalassemia.
- Published on
Pathology - Glucose-6-Phosphate Dehydrogenase Deficiency Anemia
Causes and Distribution of Diseases
This is a genetic condition that is inherited in an X-linked recessive manner. It leads to a shortage of an enzyme called glucose-6-phosphate dehydrogenase (G6PD).Impacts a demographic of 10%-15% of individuals of African descent
Pathology
Peripheral blood smear reveals the presence of bite cells and Heinz bodies, which are clusters of oxidized hemoglobin within the red blood cells.
Pathophysiology refers to the study of the functional changes that occur in the body as a result of a disease or injury. G6PD is an enzyme that participates in the synthesis of NADPH in the hexose monophosphate shunt pathway. NADPH is essential for the production of reduced glutathione, a molecule that plays a crucial role in safeguarding hemoglobin against oxidative harm.
In the absence of reduced glutathione, hemoglobin undergoes oxidation and leads to the formation of Heinz bodies within the red blood cells. Heinz bodies induce harm to the red blood cell (RBC) membrane, resulting in the elimination of these impaired RBCs in the spleen, ultimately causing anemia.
Clinical Presentations
Episodic hemolytic anemia with hemoglobinuria can occur when oxidant medications such as primaquine, quinidine, quinine, sulfonamides, and anti-TB treatments are ingested. It can also be caused by the consumption of certain foods, namely fava beans, in the presence of infection.
Treatment: Refrain from administering medications with oxidizing properties.
G6PD deficiency is associated with an elevated level of resistance to malaria.
Causes and Distribution of Diseases
This is a genetic condition that is inherited in an X-linked recessive manner. It leads to a shortage of an enzyme called glucose-6-phosphate dehydrogenase (G6PD).Impacts a demographic of 10%-15% of individuals of African descent
Pathology
Peripheral blood smear reveals the presence of bite cells and Heinz bodies, which are clusters of oxidized hemoglobin within the red blood cells.
Pathophysiology refers to the study of the functional changes that occur in the body as a result of a disease or injury. G6PD is an enzyme that participates in the synthesis of NADPH in the hexose monophosphate shunt pathway. NADPH is essential for the production of reduced glutathione, a molecule that plays a crucial role in safeguarding hemoglobin against oxidative harm.
In the absence of reduced glutathione, hemoglobin undergoes oxidation and leads to the formation of Heinz bodies within the red blood cells. Heinz bodies induce harm to the red blood cell (RBC) membrane, resulting in the elimination of these impaired RBCs in the spleen, ultimately causing anemia.
Clinical Presentations
Episodic hemolytic anemia with hemoglobinuria can occur when oxidant medications such as primaquine, quinidine, quinine, sulfonamides, and anti-TB treatments are ingested. It can also be caused by the consumption of certain foods, namely fava beans, in the presence of infection.
Treatment: Refrain from administering medications with oxidizing properties.
G6PD deficiency is associated with an elevated level of resistance to malaria.
- Published on
Pathology - Paroxysmal Nocturnal Hemoglobinuria (PNH)
Resulting from a genetic alteration on the X chromosome. This leads to the incapacity of hematopoietic stem cells to generate a GPI surface protein, which plays a crucial role in interacting with complement molecules. This results in flawed interactions with complement, leading to the destruction of the erythrocyte by complement.
Pathology
Peripheral blood smear reveals indications of hemolytic anemia.
Patients exhibit intermittent reddish-brown urine in the mornings as a result of elevated levels of urine hemosiderin. Indications of hemolytic anemia and blood clotting in veins.
Symptoms and signs
Additionally, certain people may exhibit infections and bleeding as a result of a pancytopenic condition.
Laboratory results: The results indicate a positive Ham test, positive urine hemosiderin, negative Coombs test, and flow cytometry showing the absence of CD55 or CD59, which are both GPI surface proteins.
Therapy
Supportive therapy include transfusions and iron supplementation as necessary; corticosteroids for mild cases, while severe cases may necessitate a bone marrow transplant or immunosuppression using eculizumab.
Resulting from a genetic alteration on the X chromosome. This leads to the incapacity of hematopoietic stem cells to generate a GPI surface protein, which plays a crucial role in interacting with complement molecules. This results in flawed interactions with complement, leading to the destruction of the erythrocyte by complement.
Pathology
Peripheral blood smear reveals indications of hemolytic anemia.
Patients exhibit intermittent reddish-brown urine in the mornings as a result of elevated levels of urine hemosiderin. Indications of hemolytic anemia and blood clotting in veins.
Symptoms and signs
Additionally, certain people may exhibit infections and bleeding as a result of a pancytopenic condition.
Laboratory results: The results indicate a positive Ham test, positive urine hemosiderin, negative Coombs test, and flow cytometry showing the absence of CD55 or CD59, which are both GPI surface proteins.
Therapy
Supportive therapy include transfusions and iron supplementation as necessary; corticosteroids for mild cases, while severe cases may necessitate a bone marrow transplant or immunosuppression using eculizumab.
- Published on
Pathology – Sickle Cell Anemia
Sickle Cell Anemia is a genetic disorder characterized by abnormal red blood cells that have a sickle shape.
This is an autosomal recessive condition that leads to the development of Hgb S. Hemoglobin S is the result of a genetic mutation that involves the substitution of glutamine with valine in the gene responsible for coding the beta-globin chain of hemoglobin.
Approximately 8% of individuals of African descent possess the Hob S gene.
Pathology
The examination of the blood sample reveals the presence of crescent-shaped red blood cells, Howell-Jolly bodies, and an increased number of immature red blood cells.
Pathophysiology refers to the study of the functional changes that occur in the body as a result of a disease or injury. Hemoglobin S undergoes polymerization in low-oxygen conditions, which can be triggered by factors such as infection, physical activity, or dehydration. resulting in the deformation of red blood cell morphology and increased vulnerability to hemolysis
Symptoms and Signs
Chronic hemolytic anemia, a condition characterized by the breakdown of red blood cells, can result in jaundice and leg ulcers. It can also cause vaso-occlusive crises, which are episodes of severe pain in the back or limbs due to blockage of small blood vessels by sickled cells. The repeated infarction of the spleen can lead to auto-splenectomy. Additionally, aplastic crises, often triggered by Parvovirus BIS infection, may occur. Individuals with this condition are more susceptible to infections caused by encapsulated organisms such as Salmonella. On imaging, a "Crew cut" appearance can be observed on skull x-rays due to expansion of the bone marrow.
Therapy
Supportive measures such as blood transfusions, administration of fluids, pain management, and oxygen therapy are recommended during episodes of hemolytic and vaso-occlusive crises. In severe cases of vaso-occlusive crises, plasma exchange may be considered, particularly for conditions like stroke or acute chest syndrome. Additionally, hydroxyurea can be prescribed to patients who experience recurrent crises as it helps increase levels of Hgb F. Allogeneic hematopoietic stem cell transplantation for a life-threatening condition.
Individuals diagnosed with Hgb C illness, which is caused by a distinct mutation in the B-chain of hemoglobin, and those who have sickle cell trait, meaning they carry one copy of the Hgb S gene, typically experience less severe forms of sickle cell anemia.
The presence of the Hgb S gene confers immunity against Plasmodium falciparum malaria.
Sickle Cell Anemia is a genetic disorder characterized by abnormal red blood cells that have a sickle shape.
This is an autosomal recessive condition that leads to the development of Hgb S. Hemoglobin S is the result of a genetic mutation that involves the substitution of glutamine with valine in the gene responsible for coding the beta-globin chain of hemoglobin.
Approximately 8% of individuals of African descent possess the Hob S gene.
Pathology
The examination of the blood sample reveals the presence of crescent-shaped red blood cells, Howell-Jolly bodies, and an increased number of immature red blood cells.
Pathophysiology refers to the study of the functional changes that occur in the body as a result of a disease or injury. Hemoglobin S undergoes polymerization in low-oxygen conditions, which can be triggered by factors such as infection, physical activity, or dehydration. resulting in the deformation of red blood cell morphology and increased vulnerability to hemolysis
Symptoms and Signs
Chronic hemolytic anemia, a condition characterized by the breakdown of red blood cells, can result in jaundice and leg ulcers. It can also cause vaso-occlusive crises, which are episodes of severe pain in the back or limbs due to blockage of small blood vessels by sickled cells. The repeated infarction of the spleen can lead to auto-splenectomy. Additionally, aplastic crises, often triggered by Parvovirus BIS infection, may occur. Individuals with this condition are more susceptible to infections caused by encapsulated organisms such as Salmonella. On imaging, a "Crew cut" appearance can be observed on skull x-rays due to expansion of the bone marrow.
Therapy
Supportive measures such as blood transfusions, administration of fluids, pain management, and oxygen therapy are recommended during episodes of hemolytic and vaso-occlusive crises. In severe cases of vaso-occlusive crises, plasma exchange may be considered, particularly for conditions like stroke or acute chest syndrome. Additionally, hydroxyurea can be prescribed to patients who experience recurrent crises as it helps increase levels of Hgb F. Allogeneic hematopoietic stem cell transplantation for a life-threatening condition.
Individuals diagnosed with Hgb C illness, which is caused by a distinct mutation in the B-chain of hemoglobin, and those who have sickle cell trait, meaning they carry one copy of the Hgb S gene, typically experience less severe forms of sickle cell anemia.
The presence of the Hgb S gene confers immunity against Plasmodium falciparum malaria.
- Published on
Pathology - Autoimmune Hemolytic Anemias
Warm antibody autoimmune hemolytic anemia (WAIHA) is characterized by the presence of IgG antibodies that target the red blood cell (RBC) membrane. The development of these IgG antibodies can occur without a known cause (idiopathic) or as a result of an underlying condition such as stem cell disorders or lymphomas.
Cold agglutinin illness is a condition where large IgM antibodies target and bind to the I antigen on red blood cells, causing them to be engulfed by phagocytes. The development of these IgM antibodies is often of unknown cause (idiopathic) or can be associated with Waldenstrom macroglobulinemia. Infectious mononucleosis. or infection caused by Mycoplasma pneumoniae
In addition to WAIHA and cold agglutinin illness, autoimmune hemolytic anemia (AIHA) can also be caused by some pharmacological agents such as sulfa medications, quinidine, and rifampin.
Study of the nature and causes of diseases.
WAIHA: The examination of the blood sample shows the presence of microspherocytes, which are erythrocytes that are spherical in shape and lack a central pale area. Additionally, there is an increased number of reticulocytes.
CAD: The examination of a sample of peripheral blood reveals the presence of microspherocytes, which are erythrocytes that are spherical in shape and lack a core area of pallor. Additionally, there is an increased number of reticulocytes.
Symptoms and signs
WAIHA: Severe destruction of red blood cells, resulting in jaundice and enlargement of the spleen. Laboratory results include a positive direct Coombs test, reduced hematocrit, raised lactate dehydrogenase (LDH), and elevated indirect bilirubin.
CAD: Cold-induced hemolytic anemia resulting in jaundice. Laboratory results include a positive cold agglutinin test, reduced hemoglobin, raised lactate dehydrogenase (LDH), and elevated indirect bilirubin.
Therapy
WAIHA: Administer appropriate treatment for the root cause of the condition, such as steroids, intravenous immune globulin, and/or splenectomy in severe instances.
CAD: Severe instances should be protected from cold environments and measures should be taken to avoid immunosuppression.
The direct Coombs test examines the existence of antibodies on the surface of red blood cells (RBCs). The indirect Coombs test evaluates the existence of unbound antibodies in the patient's serum.
Warm antibody autoimmune hemolytic anemia (WAIHA) is characterized by the presence of IgG antibodies that target the red blood cell (RBC) membrane. The development of these IgG antibodies can occur without a known cause (idiopathic) or as a result of an underlying condition such as stem cell disorders or lymphomas.
Cold agglutinin illness is a condition where large IgM antibodies target and bind to the I antigen on red blood cells, causing them to be engulfed by phagocytes. The development of these IgM antibodies is often of unknown cause (idiopathic) or can be associated with Waldenstrom macroglobulinemia. Infectious mononucleosis. or infection caused by Mycoplasma pneumoniae
In addition to WAIHA and cold agglutinin illness, autoimmune hemolytic anemia (AIHA) can also be caused by some pharmacological agents such as sulfa medications, quinidine, and rifampin.
Study of the nature and causes of diseases.
WAIHA: The examination of the blood sample shows the presence of microspherocytes, which are erythrocytes that are spherical in shape and lack a central pale area. Additionally, there is an increased number of reticulocytes.
CAD: The examination of a sample of peripheral blood reveals the presence of microspherocytes, which are erythrocytes that are spherical in shape and lack a core area of pallor. Additionally, there is an increased number of reticulocytes.
Symptoms and signs
WAIHA: Severe destruction of red blood cells, resulting in jaundice and enlargement of the spleen. Laboratory results include a positive direct Coombs test, reduced hematocrit, raised lactate dehydrogenase (LDH), and elevated indirect bilirubin.
CAD: Cold-induced hemolytic anemia resulting in jaundice. Laboratory results include a positive cold agglutinin test, reduced hemoglobin, raised lactate dehydrogenase (LDH), and elevated indirect bilirubin.
Therapy
WAIHA: Administer appropriate treatment for the root cause of the condition, such as steroids, intravenous immune globulin, and/or splenectomy in severe instances.
CAD: Severe instances should be protected from cold environments and measures should be taken to avoid immunosuppression.
The direct Coombs test examines the existence of antibodies on the surface of red blood cells (RBCs). The indirect Coombs test evaluates the existence of unbound antibodies in the patient's serum.
- Published on
Pathology - Pathology - Erythroblastosis Fetalis
Erythroblastosis Fetalis is a medical condition characterized by the presence of immature red blood cells in the fetus.
The occurrence of ABO incompatibility or Rh antigen incompatibility, typically involving the fetal D antigen, between the mother and fetus.
Pathology
Peripheral blood smear analysis reveals an increased presence of immature red blood cells known as erythroblasts, indicating reticuloctosis.
Pathophysiology: Maternal alloimmunization occurs when the mother's immune system becomes sensitized to fetal red blood cell antigens, typically due to exposure to fetal Rh antigens in a previous pregnancy. leads to the activation of maternal antibodies that target fetal red blood cells
Symptoms and signs
Severe fetal hemolytic anemia leads to the production of red blood cells outside the bone marrow, causing a rise in indirect bilirubin levels. This results in the development of jaundice and can lead to a condition called kernicterus. In severe instances, there may be fetal heart failure accompanied by widespread swelling, or the pregnancy may result in a stillbirth.
Therapeutic interventions
Administer blood transfusions when necessary.
Preventive approaches involve administering anti-DiGg to D-negative women during the delivery of a D-positive child.
Erythroblastosis Fetalis is a medical condition characterized by the presence of immature red blood cells in the fetus.
The occurrence of ABO incompatibility or Rh antigen incompatibility, typically involving the fetal D antigen, between the mother and fetus.
Pathology
Peripheral blood smear analysis reveals an increased presence of immature red blood cells known as erythroblasts, indicating reticuloctosis.
Pathophysiology: Maternal alloimmunization occurs when the mother's immune system becomes sensitized to fetal red blood cell antigens, typically due to exposure to fetal Rh antigens in a previous pregnancy. leads to the activation of maternal antibodies that target fetal red blood cells
Symptoms and signs
Severe fetal hemolytic anemia leads to the production of red blood cells outside the bone marrow, causing a rise in indirect bilirubin levels. This results in the development of jaundice and can lead to a condition called kernicterus. In severe instances, there may be fetal heart failure accompanied by widespread swelling, or the pregnancy may result in a stillbirth.
Therapeutic interventions
Administer blood transfusions when necessary.
Preventive approaches involve administering anti-DiGg to D-negative women during the delivery of a D-positive child.
- Published on
Pathology – Aplastic Anemia
Aplastic anemia is a medical condition characterized by the failure of the bone marrow to produce an adequate amount of red blood cells, white blood cells, and platelets. The exact cause of aplastic anemia is not fully understood.
The causes of idiopathic aplastic anemia include radiation exposure, benzene exposure, certain medications such as chloramphenicol and alkylating agents, as well as autoimmune malfunction of cytotoxic T lymphocytes. Additionally, viral infections such as Parvovirus B19, EBV, HIV, hepatitis C, and autoimmune illnesses including systemic lupus erythematosus (SLE) can also contribute to the development of this condition.
Pathology
The bone marrow exhibits hypocellularity, characterized by a decrease in the number of cells. Additionally, there is evidence of fatty alteration, but no presence of hematopoietic cells.
Peripheral blood smear reveals pancytopenia, characterized by a decrease in all types of blood cells, but with normal appearance and structure of the cells.
Medical Presentation
The individual exhibits symptoms of anemia, including fatigue, malaise, and pallor. Additionally, they have neutropenia, which is characterized by infections, and thrombocytopenia, which is indicated by mucosal bleeding, purpura, or petechiae. There is no enlargement of the liver or spleen.
Therapy
Transfusions will be given as necessary. G-CS or GM-CSF will be administered. An allogenic bone marrow transplant may be performed. The causative medicine will be stopped. Immunosuppression will be achieved with cyclosporine.
Aplastic anemia is a medical condition characterized by the failure of the bone marrow to produce an adequate amount of red blood cells, white blood cells, and platelets. The exact cause of aplastic anemia is not fully understood.
The causes of idiopathic aplastic anemia include radiation exposure, benzene exposure, certain medications such as chloramphenicol and alkylating agents, as well as autoimmune malfunction of cytotoxic T lymphocytes. Additionally, viral infections such as Parvovirus B19, EBV, HIV, hepatitis C, and autoimmune illnesses including systemic lupus erythematosus (SLE) can also contribute to the development of this condition.
Pathology
The bone marrow exhibits hypocellularity, characterized by a decrease in the number of cells. Additionally, there is evidence of fatty alteration, but no presence of hematopoietic cells.
Peripheral blood smear reveals pancytopenia, characterized by a decrease in all types of blood cells, but with normal appearance and structure of the cells.
Medical Presentation
The individual exhibits symptoms of anemia, including fatigue, malaise, and pallor. Additionally, they have neutropenia, which is characterized by infections, and thrombocytopenia, which is indicated by mucosal bleeding, purpura, or petechiae. There is no enlargement of the liver or spleen.
Therapy
Transfusions will be given as necessary. G-CS or GM-CSF will be administered. An allogenic bone marrow transplant may be performed. The causative medicine will be stopped. Immunosuppression will be achieved with cyclosporine.
- Published on
Pathology - Anemia of Chronic Inflammation
Due to long-term systemic conditions such as rheumatoid arthritis and persistent infection (such as HIV). or malignancy
Study of the nature and causes of diseases.
Peripheral blood smear: Exhibiting normal chromaticity. Normal-sized red blood cells
Pathophysiology refers to the study of the abnormal physiological processes that occur in the body as a result of disease or injury. Elevated levels of cytokines and hepcidin during an inflammatory state hinder the efficient use of iron by the bone marrow, resulting in reduced production of red blood cells.
Medical Presentation
Anemia is characterized by the presence of fatigue and pallor.
Laboratory results indicate a little decrease in heterozygosity, low levels of iron in the blood serum, normal to low levels of total iron-binding capacity (TIBC), and normal to increased levels of serum ferritin, suggesting an increase in iron storage in the macrophages of the bone marrow.
Therapy
Address the underlying condition: administer synthetic erythropoietin or perform blood transfusions if the condition is severe.
Due to long-term systemic conditions such as rheumatoid arthritis and persistent infection (such as HIV). or malignancy
Study of the nature and causes of diseases.
Peripheral blood smear: Exhibiting normal chromaticity. Normal-sized red blood cells
Pathophysiology refers to the study of the abnormal physiological processes that occur in the body as a result of disease or injury. Elevated levels of cytokines and hepcidin during an inflammatory state hinder the efficient use of iron by the bone marrow, resulting in reduced production of red blood cells.
Medical Presentation
Anemia is characterized by the presence of fatigue and pallor.
Laboratory results indicate a little decrease in heterozygosity, low levels of iron in the blood serum, normal to low levels of total iron-binding capacity (TIBC), and normal to increased levels of serum ferritin, suggesting an increase in iron storage in the macrophages of the bone marrow.
Therapy
Address the underlying condition: administer synthetic erythropoietin or perform blood transfusions if the condition is severe.
- Published on
Pathology - Acute Lymphoblastic Leukemia
Common risk factors encompass previous exposure to radiation and chemotherapy, as well as the presence of Down syndrome.
Most commonly observed in youth, with a median peak age of 10, but can also manifest in older individuals.
Study of the nature and causes of diseases.
Acute lymphoblastic leukemia (ALL) can be categorized as either T cell or early B cell. The presence of lymphoblastic surface antigens serves as an indication of the leukemia's genesis. Some of the antigens found on B-cells are CALLA (CD10), CD19, and CD20. T-cell antigens comprise CD2, CD5, and CD7. TaT is a characteristic of undeveloped T and B lymphocytes and is found in 95% of instances.
The bone marrow exhibits hypercellularity, primarily consisting of lymphoblasts, with a deformed architecture.
Peripheral blood smear reveals pancytopenia, characterized by a deficiency of all blood cell types, along with lymphocytosis, which is an excessive number of lymphoblasts.
Medical Presentation
Symptoms include tiredness, infections, high body temperature, bleeding from mucous membranes, swollen lymph nodes, discomfort in the bones, and nerve damage in the head.
Therapy
Treatment options may include chemotherapy and/or a bone marrow transplant.
Highly receptive to treatment with a favorable prognosis.
Every single one It is the prevalent kind of cancer that occurs in children.
Additionally, it constitutes 80% of the total cases of juvenile leukemias.
Common risk factors encompass previous exposure to radiation and chemotherapy, as well as the presence of Down syndrome.
Most commonly observed in youth, with a median peak age of 10, but can also manifest in older individuals.
Study of the nature and causes of diseases.
Acute lymphoblastic leukemia (ALL) can be categorized as either T cell or early B cell. The presence of lymphoblastic surface antigens serves as an indication of the leukemia's genesis. Some of the antigens found on B-cells are CALLA (CD10), CD19, and CD20. T-cell antigens comprise CD2, CD5, and CD7. TaT is a characteristic of undeveloped T and B lymphocytes and is found in 95% of instances.
The bone marrow exhibits hypercellularity, primarily consisting of lymphoblasts, with a deformed architecture.
Peripheral blood smear reveals pancytopenia, characterized by a deficiency of all blood cell types, along with lymphocytosis, which is an excessive number of lymphoblasts.
Medical Presentation
Symptoms include tiredness, infections, high body temperature, bleeding from mucous membranes, swollen lymph nodes, discomfort in the bones, and nerve damage in the head.
Therapy
Treatment options may include chemotherapy and/or a bone marrow transplant.
Highly receptive to treatment with a favorable prognosis.
Every single one It is the prevalent kind of cancer that occurs in children.
Additionally, it constitutes 80% of the total cases of juvenile leukemias.
- Published on
Dermatology - Spider Angioma
Spider angioma is a medical condition characterized by the presence of a red, spider-like lesion on the skin.
Spider angiomas are a prevalent occurrence that can manifest at any age. They are more prevalent in females and may be linked to conditions characterized by high levels of estrogen, such as pregnancy (occurring in approximately two-thirds of pregnant women), estrogen therapy (e.g., oral contraceptives), or hepatocellular diseases like subacute and chronic viral hepatitis and alcoholic cirrhosis. Lesions that develop during childhood or pregnancy have the potential to naturally diminish over time.
A crimson focal telangiectatic network of expanded capillaries, measuring up to 1.5 cm in diameter, extends outward from a central arteriole (punctum). The central raised spot is where the artery that supplies nutrients to the area is located, surrounded by blood vessels that spread out like branches. The lesion often appears as a single occurrence and is most commonly found on the face, forearms, and hands. During diascopy, the telangiectasia that radiates from the center becomes pale when pressure is applied, and the central arteriole may exhibit pulsation.
The diagnosis is primarily based on clinical evaluation, and the possible conditions to consider are inherited hemorrhagic telangiectasia, ataxia-telangiectasia, or telangiectasia in systemic scleroderma.
Spider angiomas are a non-cancerous abnormality of blood vessels. Laser therapy and electrosurgery are both efficacious for achieving desired cosmetic outcomes.
Spider angioma is a medical condition characterized by the presence of a red, spider-like lesion on the skin.
Spider angiomas are a prevalent occurrence that can manifest at any age. They are more prevalent in females and may be linked to conditions characterized by high levels of estrogen, such as pregnancy (occurring in approximately two-thirds of pregnant women), estrogen therapy (e.g., oral contraceptives), or hepatocellular diseases like subacute and chronic viral hepatitis and alcoholic cirrhosis. Lesions that develop during childhood or pregnancy have the potential to naturally diminish over time.
A crimson focal telangiectatic network of expanded capillaries, measuring up to 1.5 cm in diameter, extends outward from a central arteriole (punctum). The central raised spot is where the artery that supplies nutrients to the area is located, surrounded by blood vessels that spread out like branches. The lesion often appears as a single occurrence and is most commonly found on the face, forearms, and hands. During diascopy, the telangiectasia that radiates from the center becomes pale when pressure is applied, and the central arteriole may exhibit pulsation.
The diagnosis is primarily based on clinical evaluation, and the possible conditions to consider are inherited hemorrhagic telangiectasia, ataxia-telangiectasia, or telangiectasia in systemic scleroderma.
Spider angiomas are a non-cancerous abnormality of blood vessels. Laser therapy and electrosurgery are both efficacious for achieving desired cosmetic outcomes.
